Teladoc Health Inc. [NYSE: TDOC] traded at a high on 08/24/22, posting a 2.75 gain after which it closed the day’ session at $33.66. The company report on August 10, 2022 that Teladoc Health Makes A1C Testing Easier for Members with Diabetes.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
At-Home Testing Improves Diabetes Care & Control for Individuals, Providers & Payers Alike.
Teladoc Health (NYSE: TDOC), the global leader in whole-person care, announced today the addition of a home A1C testing program to its Livongo by Teladoc Health chronic care solution, making it easier for members to manage and control their diabetes. Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and care directly into the homes of patients. The announcement comes as new company data shows that 58% of members opt for the at-home service when given the chance, with a three to four times greater consumer test return rate than other options on the market.
The results of the trading session contributed to over 2758184 shares changing hands. Over the past one week, the price volatility of Teladoc Health Inc. stands at 4.70% while the volatility over the past one month is 6.64%.
The market cap for TDOC stock reached $5.80 billion, with 161.38 million shares outstanding and 159.73 million shares in the current float. Compared to the average trading volume of 5.49M shares, TDOC reached a trading volume of 2758184 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Teladoc Health Inc. [TDOC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $36.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Sell, with their previous recommendation back on August 17, 2022. While these analysts kept the previous recommendation, DA Davidson raised their target price to Buy. The new note on the price target was released on August 12, 2022, representing the official price target for Teladoc Health Inc. stock. Previously, the target price had yet another drop from $58 to $34, while Cowen kept a Market Perform rating on TDOC stock.
The Average True Range (ATR) for Teladoc Health Inc. is set at 2.71, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 2.60. The Price to Book ratio for the last quarter was 0.89, with the Price to Cash per share for the same quarter was set at 5.13. Price to Free Cash Flow for TDOC in the course of the last twelve months was 27.63 with Quick ratio for the last quarter at 3.20.
How has TDOC stock performed recently?
Teladoc Health Inc. [TDOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.37. With this latest performance, TDOC shares dropped by -16.25% in over the last four-week period, additionally sinking by -45.23% over the last 6 months – not to mention a drop of -76.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 41.45, with the RSI for the last a single of trading hit 38.07, and the three-weeks RSI is set at 43.59 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 37.20, while it was recorded at 33.42 for the last single week of trading, and 63.08 for the last 200 days.
Teladoc Health Inc. [TDOC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -11.76 and a Gross Margin at +57.96. Teladoc Health Inc.’s Net Margin is presently recorded at -21.09.
Return on Equity for this stock declined to -2.69, with Return on Assets sitting at -2.35.
Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.20 and a Current Ratio set at 3.40.
Insider trade positions for Teladoc Health Inc. [TDOC]
There are presently around $4,801 million, or 86.50% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 20,293,962, which is approximately 4.248% of the company’s market cap and around 0.50% of the total institutional ownership; VANGUARD GROUP INC, holding 13,560,448 shares of the stock with an approximate value of $456.44 million in TDOC stocks shares; and BLACKROCK INC., currently with $368.6 million in TDOC stock with ownership of nearly 2.2% of the company’s market capitalization.
Positions in Teladoc Health Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 279 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 27,166,657 shares. Additionally, 365 investors decreased positions by around 22,976,254 shares, while 96 investors held positions by with 92,489,476 shares. The mentioned changes placed institutional holdings at 142,632,387 shares, according to the latest SEC report filing. TDOC stock had 67 new institutional investments in for a total of 7,433,483 shares, while 189 institutional investors sold positions of 4,014,078 shares during the same period.